Kidney stones: Pathology review

12,236views

Kidney stones: Pathology review

Watch later

Watch later

Coronary artery disease: Clinical
Inflammatory bowel disease: Pathology review
Crohn disease
Ulcerative colitis
Inflammatory bowel disease: Clinical
Macrocytic anemia: Pathology review
Anemia: Clinical
Extrinsic hemolytic normocytic anemia: Pathology review
Microcytic anemia: Pathology review
Sideroblastic anemia
Autoimmune hemolytic anemia
Iron deficiency anemia
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Anemia of chronic disease
Folate (Vitamin B9) deficiency
Pancreatitis: Pathology review
Pancreatitis: Clinical
Acute pancreatitis
Chronic pancreatitis
Superior mesenteric artery syndrome
Diverticulosis and diverticulitis
Diverticular disease: Pathology review
Diverticular disease: Clinical
Appendicitis: Clinical
Appendicitis
Appendicitis: Pathology review
Irritable bowel syndrome
Anatomy of the abdominal viscera: Large intestine
Vitamin B12 deficiency
Myocardial infarction
ECG cardiac infarction and ischemia
Clot retraction and fibrinolysis
Platelet plug formation (primary hemostasis)
Erythropoietin
Coagulation (secondary hemostasis)
Atrial fibrillation
Anticoagulants: Warfarin
Heart failure
Heart failure: Pathology review
Heart failure: Clinical
Ventricular fibrillation
Ventricular tachycardia
Class III antiarrhythmics: Potassium channel blockers
Atrial flutter
Ventricular arrhythmias: Pathology review
Supraventricular arrhythmias: Pathology review
Acute kidney injury: Clinical
Kidney stones: Pathology review
Kidney stones
Glomerular filtration
Long QT syndrome and Torsade de pointes
Hyperkalemia
Hyperkalemia: Clinical
Chronic kidney disease
Chronic kidney disease: Clinical
Hyperphosphatemia
Hypercalcemia
Kidney stones: Clinical
Renal failure: Pathology review
Diabetes mellitus: Clinical
Metabolic acidosis
Class I antiarrhythmics: Sodium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Class II antiarrhythmics: Beta blockers
Positive inotropic medications
Hyponatremia: Clinical
Hyponatremia
Hypernatremia: Clinical
Hypernatremia
Chronic obstructive pulmonary disease (COPD): Clinical
Obstructive lung diseases: Pathology review
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Emphysema
Pulmonary hypertension
Cor pulmonale
Chronic bronchitis
Muscarinic antagonists
Asthma: Clinical
Asthma
Pulmonary embolism
Deep vein thrombosis and pulmonary embolism: Pathology review
Venous thromboembolism: Clinical
Pneumonia: Pathology review
Pneumonia
Pneumonia: Clinical
Ventilation-perfusion ratios and V/Q mismatch
Shock: Clinical
Shock: Pathology review
Shock
Factor V Leiden
Anticoagulants: Heparin
Hyperthyroidism medications
Hyperthyroidism: Pathology review
Hyperthyroidism: Clinical
Hypothyroidism and thyroiditis: Clinical
Hypothyroidism: Pathology review
Hypothyroidism medications
Pheochromocytoma
Adrenal masses: Pathology review
Renal artery stenosis
Hyperaldosteronism
Respiratory distress syndrome: Pathology review
Acute respiratory distress syndrome: Clinical
Diabetes insipidus and SIADH: Pathology review
Pericardial disease: Clinical
Dementia and delirium: Clinical
Dementia with Lewy bodies
Alzheimer disease
Parkinson disease
Anti-parkinson medications
Traumatic brain injury: Clinical
Concussion and traumatic brain injury
Brown-Sequard Syndrome
Cauda equina syndrome
Meningitis
Myasthenia gravis
Multiple sclerosis
Stroke: Clinical
Cerebral vascular disease: Pathology review
Alcohol use disorder
Seizures: Clinical

Transcript

Watch video only

In the Emergency Department, two people with similar symptoms came in.

One of them is 35 year old Conrad who has a terrible left flank pain, along with nausea and vomiting and the other one is 40 year old Sam who has left flank pain, but also has dysuria.

An electrolyte panel and urinalysis was done in both individuals.

Results showed that Conrad had normal levels of calcium in the blood, but urinalysis showed hypercalciuria and hematuria.

Sam’s urinalysis showed positive leukocyte esterase, as well as positive nitrites and hematuria. Abdominal CT showed radiopaque masses in their ureters.

Now, the suspicion is that both individuals have kidney stones, but there are actually several types of kidney stones and we need to know what we’re dealing with in order to give the right treatment.

Okay, let’s first talk about how kidney stones form.

Urine’s a combination of water, which acts as a solvent, and all sorts of particles, or solutes.

In general, when certain solutes become too concentrated in the solvent, they become supersaturated.

Urinary supersaturation of certain solutes results in precipitation out of the solution and formation of crystals.

Those crystals then act as a nidus, or place where more solutes can deposit and over time it builds up a crystalline structure.

This can happen if there’s an increase in the solute, or a decrease in the solvent, as would be the case with dehydration.

This means that dehydration leads to a low urine volume which can further put a person at risk for kidney stones.

Okay, let’s now talk about the different types of stones.

There are four main types of stones.

Calcium stones are present in about 80 percent of the cases, while struvite stones are present in about 15 percent of the cases and uric acid stones are present in about 5 percent of the cases.

Finally, a super rare type of stone is a cysteine stone.

Let’s start with calcium stones.

With calcium stones, in most cases, the inorganic precipitate is calcium oxalate, formed by a positively charged calcium ion binding to a negatively charged oxalate ion, which results in a black or dark brown colored stone that’s shaped like an envelope or a dumbbell.

Calcium oxalate stones appear radiopaque on X-ray, as well as on a CT-scan.

Now, there are some risk factors for developing calcium stones, such as idiopathic hypercalciuria or hypercalcemia.

Another very important risk factor is hypocitraturia, which means that less citrate is eliminated in the urine.

This is because normally, citrate prevents stone formation by inhibiting crystal growth and aggregation.

Other risk factors include fat malabsorption, which can happen with Crohn’s disease or in individuals that have had a gastric bypass operation.

This happens because since fat won’t be absorbed in the intestine, it will bind to calcium and this leaves a lot of oxalate free to be absorbed in the intestine, which raises oxalate levels in the blood and can further promote calcium oxalate stone formation.

Another risk factor is the ingestion of ethylene glycol or antifreeze, because ethylene glycol forms oxalate once ingested.

Finally, there’s vitamin C abuse, because one product of vitamin C metabolism is oxalate.

Now, treatment of calcium-oxalate stones involves giving thiazide diuretics.

Thiazides inhibit the sodium-chloride transporter in the distal convoluted tubule, meaning that more sodium and chloride get in the urine.

Okay, the distal convoluted tubule also has a calcium channel which allows calcium from the lumen to diffuse into the cell.

Once in the cell, calcium is transported out into the interstitium through a sodium-calcium exchanger, that pumps a sodium in, and a calcium out.

Now, since thiazides decrease sodium reabsorption, there’s less sodium in the cell, so the sodium-calcium exchanger works overtime to pump more sodium in, and more calcium out.

The decrease in intracellular calcium, in turn, leads to more calcium reabsorption from the urine. Another treatment is giving potassium citrate which binds to the calcium in urine, preventing reabsorption.

Finally, another treatment involves a low-sodium diet.

That’s because when a person has a high sodium diet, more water is retained.

This means that the extracellular volume expands.

Since there’s so much water and sodium, the renin-angiotensin-aldosterone system has nothing to respond to, so its activity is dialed down.

This means that not that much sodium will be reabsorbed in the proximal convoluted tubule.

Now, calcium and sodium reabsorption are tied together in the proximal convoluted tubule, so when there’s less sodium reabsorption, there’s also less calcium reabsorption and there will be hypercalciuria.

Sometimes, instead of oxalate, the calcium bind to negatively charged phosphate groups to form calcium phosphate stones.

These are dirty white in color and shaped like a wedge prism which appears radiopaque on a X-ray.

A risk factor is highly alkaline urine which could be caused by renal tubular acidosis where there’s a decreased secretion of hydrogen or increased secretion of bicarbonate into the urine. Treatment includes a low-sodium diet, as well as thiazide diuretics.

Another type are struvite stones, sometimes called infection stones, which are a composite mix of magnesium, ammonium, and phosphate.

Since they are infections stones, this means that the individual can present with signs of a urinary tract infection, like dysuria.

For your tests, remember that these form when there’s an overabundance of urease-positive bugs like Proteus mirabilis, Staphylococcus saprophyticus, and Klebsiella species.

They use the enzyme urease to split urea into ammonia and carbon dioxide.

The ammonia makes the urine more alkaline and favors precipitation of magnesium, ammonium, and phosphate into jagged crystals called “staghorn” because they often branch into the several of the renal calyces and look like the horns of a staghorn deer.

On an X-ray or on a CT-scan, such stones are radiopaque,, but are less dense than calcium stones.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Practical Renal Pathology, A Diagnostic Approach E-Book" Elsevier Health Sciences (2012)
  4. "An Update and Practical Guide to Renal Stone Management" Nephron Clinical Practice (2010)
  5. "Kidney stone disease" Journal of Clinical Investigation (2005)
  6. "HELICAL CT OF URINARY TRACT STONES" Radiologic Clinics of North America (1999)